Literature DB >> 16284283

The role of eosinophils in inflammatory bowel disease.

S Al-Haddad1, R H Riddell.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16284283      PMCID： PMC1774805          DOI： 10.1136/gut.2005.072595

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  30 in total

Review 1.  T cells in inflammatory bowel disease: protective and pathogenic roles.

Authors:  F Powrie
Journal:  Immunity       Date:  1995-08       Impact factor: 31.745

Review 2.  Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation.

Authors:  T Yamada; M B Grisham
Journal:  Klin Wochenschr       Date:  1991-12-15

3.  Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis.

Authors:  T King; W Biddle; P Bhatia; J Moore; P B Miner
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

4.  Histamine release from gut mast cells from patients with inflammatory bowel diseases.

Authors:  H Nolte; N Spjeldnaes; A Kruse; B Windelborg
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

5.  Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors.

Authors:  J A Gonzalo; C M Lloyd; L Kremer; E Finger; C Martinez-A; M H Siegelman; M Cybulsky; J C Gutierrez-Ramos
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

6.  Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease.

Authors:  S C Bischoff; J Wedemeyer; A Herrmann; P N Meier; C Trautwein; Y Cetin; H Maschek; M Stolte; M Gebel; M P Manns
Journal:  Histopathology       Date:  1996-01       Impact factor: 5.087

7.  Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma.

Authors:  B Wallaert; P Desreumaux; M C Copin; I Tillie; A Benard; J F Colombel; B Gosselin; A B Tonnel; A Janin
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

8.  Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.

Authors:  E A Garcia-Zepeda; M E Rothenberg; R T Ownbey; J Celestin; P Leder; A D Luster
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

9.  Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis.

Authors:  P Desreumaux; F Bloget; D Seguy; M Capron; A Cortot; J F Colombel; A Janin
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

10.  Cloning, expression, and characterization of the human eosinophil eotaxin receptor.

Authors:  B L Daugherty; S J Siciliano; J A DeMartino; L Malkowitz; A Sirotina; M S Springer
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307
View more
  24 in total

1.  Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy.

Authors:  Giuseppe Leoncini; Vincenzo Villanacci; Maria Grazia Marin; Valentina Crisafulli; Moris Cadei; Elisabetta Antonelli; Claudio Leoci; Gabrio Bassotti
Journal:  Tech Coloproctol       Date:  2018-12-10       Impact factor: 3.781

2.  Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration.

Authors:  SuFey Ong; Davinna L Ligons; Jobert G Barin; Lei Wu; Monica V Talor; Nicola Diny; Jillian A Fontes; Elizabeth Gebremariam; David A Kass; Noel R Rose; Daniela Čiháková
Journal:  Am J Pathol       Date:  2015-01-23       Impact factor: 4.307

3.  Classification of eosinophilic disorders of the small and large intestine.

Authors:  Aoife J McCarthy; Kieran Sheahan
Journal:  Virchows Arch       Date:  2017-11-10       Impact factor: 4.064

4.  The ubiquitin ligase adaptor Ndfip1 regulates T cell-mediated gastrointestinal inflammation and inflammatory bowel disease susceptibility.

Authors:  H E Ramon; C R Riling; J Bradfield; B Yang; H Hakonarson; P M Oliver
Journal:  Mucosal Immunol       Date:  2010-10-20       Impact factor: 7.313

Review 5.  Gastrointestinal eosinophils in health, disease and functional disorders.

Authors:  Nicholas Powell; Marjorie M Walker; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02-02       Impact factor: 46.802

6.  Recurrent blood eosinophilia in ulcerative colitis is associated with severe disease and primary sclerosing cholangitis.

Authors:  Arthur Barrie; Marwa El Mourabet; Katherine Weyant; Kofi Clarke; Mahesh Gajendran; Claudia Rivers; Seo Young Park; Douglas Hartman; Melissa Saul; Miguel Regueiro; Dhiraj Yadav; David G Binion
Journal:  Dig Dis Sci       Date:  2012-08-02       Impact factor: 3.199

7.  Comparison of 18F-FDG PET-MR and fecal biomarkers in the assessment of disease activity in patients with ulcerative colitis.

Authors:  Yan Li; Michael Khamou; Benedikt Michael Schaarschmidt; Lale Umutlu; Michael Forsting; Aydin Demircioglu; Johannes Haubold; Anna Katharina Koch; Nils-Martin Bruckmann; Lino Morris Sawicki; Ken Herrmann; James Hunter Boone; Jost Langhorst
Journal:  Br J Radiol       Date:  2020-06-24       Impact factor: 3.039

Review 8.  Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases.

Authors:  Eva Maria Sturm; Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 9.  Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease.

Authors:  Dickson Kofi Wiredu Ocansey; Bing Pei; Xinwei Xu; Lu Zhang; Chinasa Valerie Olovo; Fei Mao
Journal:  J Transl Med       Date:  2021-06-10       Impact factor: 5.531

Review 10.  Eosinophils and Bacteria, the Beginning of a Story.

Authors:  Edna Ondari; Esther Calvino-Sanles; Nicholas J First; Monica C Gestal
Journal:  Int J Mol Sci       Date:  2021-07-27       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.